[HTML][HTML] Outcomes associated with antiphospholipid antibodies in COVID-19: A prospective cohort study
A Mendel, MJ Fritzler, Y St-Pierre, J Rauch… - Research and Practice …, 2023 - Elsevier
Background The significance of antiphospholipid antibodies (aPL) in COVID-19 remains
uncertain. Objectives We determined whether aPL are associated with COVID-19 and/or …
uncertain. Objectives We determined whether aPL are associated with COVID-19 and/or …
Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review
M Taha, L Samavati - RMD open, 2021 - rmdopen.bmj.com
Background Many studies reported high prevalence of antiphospholipid antibodies (aPL) in
patients with COVID-19 raising questions about its true prevalence and its clinical impact on …
patients with COVID-19 raising questions about its true prevalence and its clinical impact on …
Antiphospholipid antibodies occurrence in Acute SARS-CoV-2 infection without overt thrombosis
A Dima, DN Popescu, R Moroti, E Stoica, G State… - Biomedicines, 2023 - mdpi.com
We sought to determine the prevalence of antiphospholipid antibodies (aPLs) and their
correlation with COVID-19 severity (in terms of clinical and laboratory parameters) in …
correlation with COVID-19 severity (in terms of clinical and laboratory parameters) in …
[HTML][HTML] Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome
MO Borghi, A Beltagy, E Garrafa, D Curreli… - Frontiers in …, 2020 - frontiersin.org
Background Critically ill patients with coronavirus disease 2019 (COVID-19) have a
profound hypercoagulable state and often develop coagulopathy which leads to organ …
profound hypercoagulable state and often develop coagulopathy which leads to organ …
[HTML][HTML] Antiphospholipid antibodies are enriched post-acute COVID-19 but do not modulate the thrombotic risk
M Emmenegger, V Emmenegger, SM Shambat… - Clinical …, 2023 - Elsevier
Background and objectives COVID-19-associated coagulopathy, shown to increase the risk
for the occurrence of thromboses and microthromboses, displays phenotypic features of the …
for the occurrence of thromboses and microthromboses, displays phenotypic features of the …
Prevalence, specificity and clinical association of anti-phospholipid antibodies in COVID-19 patients: are the antibodies really guilty?
MO Borghi, A Beltagy, E Garrafa, D Curreli, G Cecchini… - MedRxiv, 2020 - medrxiv.org
Background Critically ill patients with coronavirus disease 2019 (COVID-19) have a
profound hypercoagulable state and often develop coagulopathy which leads to organ …
profound hypercoagulable state and often develop coagulopathy which leads to organ …
Prothrombotic antiphospholipid antibodies in COVID-19
Y Zuo, SK Estes, RA Ali, AA Gandhi, S Yalavarthi, H Shi… - MedRxiv, 2020 - medrxiv.org
Patients with coronavirus disease 19 (COVID-19) are at high risk for thrombotic arterial and
venous occlusions. At the same time, lung histopathology often reveals fibrin-based …
venous occlusions. At the same time, lung histopathology often reveals fibrin-based …
[PDF][PDF] Frequency and clinical correlates of antiphospholipid antibodies arising in patients with SARS-CoV-2 infection: findings from a multicentre study on 122 cases
M Gatto, C Perricone, M Tonello, O Bistoni… - Clin Exp …, 2020 - clinexprheumatol.org
Objective COVID-19 features include disseminated intravascular coagulation and thrombotic
microangiopathy indicating a hypercoagulable state. We aimed to investigate …
microangiopathy indicating a hypercoagulable state. We aimed to investigate …
Persistent antiphospholipid antibodies are not associated with worse clinical outcomes in a prospective cohort of hospitalised patients with SARS-CoV-2 infection
G Espinosa, C Zamora-Martínez… - Frontiers in …, 2022 - frontiersin.org
Objective Patients with COVID-19 presented with an elevated prevalence of
antiphospholipid antibodies (aPL) but the relationship with thrombosis is controversial. We …
antiphospholipid antibodies (aPL) but the relationship with thrombosis is controversial. We …
COVID-19 and antiphospholipid antibodies: time for a reality check?
Antiphospholipid antibodies (aPL) comprise a panel of autoantibodies that reflect a potential
prothrombotic risk in several autoimmune conditions, most notably antiphospholipid …
prothrombotic risk in several autoimmune conditions, most notably antiphospholipid …